Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by fecatson Sep 14, 2023 10:51am
150 Views
Post# 35635985

RE:RE:RE:RE:RE:RE:Polish Researchers Cite Rutherrin PDT for Brain Cancer

RE:RE:RE:RE:RE:RE:Polish Researchers Cite Rutherrin PDT for Brain CancerCP, I believe you are correct and I think this has been discussed a bit here in the last week or so.It does cause me some concern if they have little ability to raise cash.Maybe BTD will make things different and this has also been discussed.But again I have concerns.Pretty much everyone here assumes it is a given for BTD. That being said.we need an influx of new buyers or the stock is going nowhere.Where will this come from ? Will buyers immediately come to the table with BTD?I recall a couple of years ago with SESN ,they released news that they had data to apply for BTD and stock was about a 10 bagger in short time.We have presented excellent data and indicate we are getting close to BTD submission and market said Big Woop.
I really dont know what will make things change.
Any thoughts are welcome
<< Previous
Bullboard Posts
Next >>